SWS Partners Has $686,000 Stake in Intuitive Surgical, Inc. (NASDAQ:ISRG)

SWS Partners trimmed its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 41.3% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 1,314 shares of the medical equipment provider’s stock after selling 926 shares during the period. SWS Partners’ holdings in Intuitive Surgical were worth $686,000 at the end of the most recent quarter.

Several other large investors have also bought and sold shares of ISRG. Howard Capital Management Group LLC boosted its position in shares of Intuitive Surgical by 4.5% in the 3rd quarter. Howard Capital Management Group LLC now owns 2,125 shares of the medical equipment provider’s stock worth $1,044,000 after purchasing an additional 92 shares during the last quarter. Farther Finance Advisors LLC lifted its stake in Intuitive Surgical by 35.1% in the third quarter. Farther Finance Advisors LLC now owns 2,900 shares of the medical equipment provider’s stock valued at $1,425,000 after buying an additional 754 shares during the period. Chicago Partners Investment Group LLC boosted its holdings in Intuitive Surgical by 1.4% during the third quarter. Chicago Partners Investment Group LLC now owns 2,461 shares of the medical equipment provider’s stock worth $1,261,000 after buying an additional 33 shares during the last quarter. Clear Creek Financial Management LLC grew its position in shares of Intuitive Surgical by 4.4% during the 3rd quarter. Clear Creek Financial Management LLC now owns 1,551 shares of the medical equipment provider’s stock worth $762,000 after buying an additional 66 shares during the period. Finally, Optas LLC increased its stake in shares of Intuitive Surgical by 13.4% in the 3rd quarter. Optas LLC now owns 651 shares of the medical equipment provider’s stock valued at $320,000 after acquiring an additional 77 shares during the last quarter. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity

In related news, VP Fredrik Widman sold 810 shares of the firm’s stock in a transaction on Monday, March 3rd. The stock was sold at an average price of $573.78, for a total transaction of $464,761.80. Following the completion of the transaction, the vice president now directly owns 473 shares of the company’s stock, valued at $271,397.94. This trade represents a 63.13 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Amal M. Johnson sold 4,635 shares of Intuitive Surgical stock in a transaction dated Tuesday, January 28th. The stock was sold at an average price of $566.60, for a total value of $2,626,191.00. Following the transaction, the director now directly owns 12,275 shares in the company, valued at $6,955,015. The trade was a 27.41 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 12,598 shares of company stock valued at $7,223,467 over the last quarter. 0.90% of the stock is owned by company insiders.

Intuitive Surgical Stock Down 1.1 %

Shares of ISRG opened at $566.98 on Tuesday. The stock has a market cap of $201.95 billion, a PE ratio of 88.45, a PEG ratio of 5.85 and a beta of 1.39. Intuitive Surgical, Inc. has a 12-month low of $364.17 and a 12-month high of $616.00. The business has a 50-day simple moving average of $570.66 and a two-hundred day simple moving average of $530.08.

Wall Street Analysts Forecast Growth

A number of research analysts recently issued reports on ISRG shares. Barclays boosted their price objective on shares of Intuitive Surgical from $610.00 to $674.00 in a report on Monday, January 27th. Wells Fargo & Company upped their price objective on shares of Intuitive Surgical from $630.00 to $687.00 and gave the company an “overweight” rating in a research report on Friday, January 24th. Royal Bank of Canada lifted their target price on Intuitive Surgical from $611.00 to $641.00 in a report on Monday, January 27th. Raymond James increased their price target on Intuitive Surgical from $560.00 to $688.00 and gave the stock an “outperform” rating in a report on Friday, January 24th. Finally, Citigroup lifted their price objective on Intuitive Surgical from $640.00 to $711.00 and gave the company a “buy” rating in a report on Friday, January 24th. One analyst has rated the stock with a sell rating, four have assigned a hold rating and sixteen have assigned a buy rating to the stock. According to MarketBeat.com, Intuitive Surgical currently has a consensus rating of “Moderate Buy” and a consensus price target of $613.10.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.